We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+8.96%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$73.6B
AUM Growth
+$1.15B
(+1.6%)
Cap. Flow
-$3.6B
Cap. Flow
% of AUM
-4.89%
Top 10 Holdings %
Top 10 Hldgs %
20.8%
Holding
3,102
New
50
Increased
790
Reduced
2,114
Closed
100
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NXP Semiconductors
NXPI
|
+$38.7M |
| 2 |
International Flavors & Fragrances
IFF
|
+$27.4M |
| 3 |
Neurocrine Biosciences
NBIX
|
+$14.7M |
| 4 |
ConocoPhillips
COP
|
+$14.5M |
| 5 |
Royalty Pharma
RPRX
|
+$9.46M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$269M |
| 2 |
Microsoft
MSFT
|
+$172M |
| 3 |
Amazon
AMZN
|
+$114M |
| 4 |
Walt Disney
DIS
|
+$62.4M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$61.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.61% |
| 2 | Financials | 14.26% |
| 3 | Healthcare | 12.86% |
| 4 | Consumer Discretionary | 12.27% |
| 5 | Industrials | 9.79% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ITI
2776
DELISTED
Iteris, Inc.
ITI
| $243K | ﹤0.01% |
39,327
-1,515
| -4% | -$9.67K |
|
|
MSON
2777
DELISTED
Misonix Inc
MSON
| $243K | ﹤0.01% |
12,379
-972
| -7% | -$16.2K |
|
2778
Eastern Company
EML
$150M
| $242K | ﹤0.01% |
9,032
-260
| -3% | -$6.64K |
|
2779
First Northwest Bancorp
FNWB
$104M
| $242K | ﹤0.01% |
14,533
-760
| -5% | -$12.6K |
|
2780
Algonquin Power & Utilities
AQN
$4.42B
| $241K | ﹤0.01% |
15,212
+1,616
| +12% | +$26.7K |
|
2781
Ardmore Shipping
ASC
$683M
| $239K | ﹤0.01% |
52,672
-1,700
| -3% | -$6.89K |
|
2782
Chemung Financial Corp
CHMG
$392M
| $239K | ﹤0.01% |
5,722
-200
| -3% | -$7.49K |
|
|
SCWX
2783
DELISTED
SecureWorks Corp Class A Common Stock
SCWX
| $237K | ﹤0.01% |
17,696
+25
| +0.1% | +$361 |
|
2784
Harvard Bioscience
HBIO
$29.2M
| $235K | ﹤0.01% |
4,299
-134
| -3% | -$6.52K |
|
|
AAIC
2785
DELISTED
Arlington Asset Investment Corp.
AAIC
| $235K | ﹤0.01% |
58,068
-3,171
| -5% | -$12.5K |
|
|
PZN
2786
DELISTED
Pzena Investment Management, Inc. Class A
PZN
| $235K | ﹤0.01% |
22,273
-1,454
| -6% | -$13.7K |
|
|
EIGR
2787
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
| $234K | ﹤0.01% |
883
-53
| -6% | -$16.7K |
|
|
FCCY
2788
DELISTED
1st Constitution Bancorp
FCCY
| $233K | ﹤0.01% |
13,214
-470
| -3% | -$8.2K |
|
|
KIN
2789
DELISTED
Kindred Biosciences, Inc.
KIN
| $233K | ﹤0.01% |
46,782
-1,870
| -4% | -$9.03K |
|
2790
Stereotaxis
STXS
$141M
| $232K | ﹤0.01% |
34,559
-4,060
| -11% | -$24.1K |
|
|
LUNA
2791
DELISTED
Luna Innovations Incorporated
LUNA
| $232K | ﹤0.01% |
22,070
-1,290
| -6% | -$14.4K |
|
2792
Capital Bancorp
CBNK
$615M
| $231K | ﹤0.01% |
11,981
-300
| -2% | -$4.91K |
|
2793
RGC Resources
RGCO
$228M
| $231K | ﹤0.01% |
10,423
-660
| -6% | -$15.5K |
|
|
PFHD
2794
DELISTED
Professional Holding Corp. Class A Common stock
PFHD
| $231K | ﹤0.01% |
12,566
-530
| -4% | -$8.89K |
|
2795
Graham Corp
GHM
$1.31B
| $230K | ﹤0.01% |
16,162
-510
| -3% | -$7.94K |
|
2796
iBio
IBIO
$70M
| $230K | ﹤0.01% |
299
+85
| +40% | +$74.1K |
|
|
RAPT
2797
DELISTED
RAPT Therapeutics
RAPT
| $230K | ﹤0.01% |
1,294
-106
| -8% | -$17.5K |
|
|
STR
2798
DELISTED
Sitio Royalties
STR
| $225K | ﹤0.01% |
12,513
-460
| -4% | -$7.3K |
|
|
SFE
2799
DELISTED
Safeguard Scientifics, Inc.
SFE
| $225K | ﹤0.01% |
32,983
-340
| -1% | -$2.47K |
|
2800
Alico
ALCO
$283M
| $224K | ﹤0.01% |
7,489
-410
| -5% | -$12.4K |
|
Similar funds
VAM
RhumbLine Advisers's Q1 2021 Portfolio in Review
As of Q1 2021, RhumbLine Advisers held 3,102 positions worth $73.6B, up 1.6% from $72.5B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
RhumbLine Advisers withdrew a net $3.6B in Q1 2021, closing 100 positions and reducing 2,114 holdings. Its most notable exit was Tiffany & Co., an estimated $26.8M position sold in full.
By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 24% a quarter earlier, followed by Financials and Healthcare.
Against the trend, RhumbLine Advisers opened a new position in NXP Semiconductors worth $42.7M.
- RhumbLine Advisers's largest Q1 2021 buy was NXP Semiconductors: 211,843 shares worth $42.7M.
- RhumbLine Advisers added most to International Flavors & Fragrances in Q1 2021, an estimated $27.4M increase.
- RhumbLine Advisers's biggest Q1 2021 reduction was Apple, cutting an estimated $269M.
- RhumbLine Advisers fully exited Tiffany & Co. in Q1 2021, selling an estimated $26.8M.
- RhumbLine Advisers's ten largest holdings make up 21% of its $73.6B portfolio in Q1 2021.
- RhumbLine Advisers opened 50 new positions and closed 100 in Q1 2021.
- RhumbLine Advisers's portfolio value rose 1.6% quarter-over-quarter to $73.6B.
Based on RhumbLine Advisers's 13F filing for Q1 2021, filed 6 May 2021.